ClinConnect ClinConnect Logo
Search / Trial NCT06280599

Transitional Care Model for Patients With Stroke

Launched by KAOHSIUNG MEDICAL UNIVERSITY · Feb 26, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a special approach to care for people who have had a stroke. It's called the Transitional Care Model, which aims to help patients recover better after their hospital stay. The trial found that this model can lead to improvements in physical abilities, like being able to perform everyday tasks, along with fewer trips to the emergency room, reduced feelings of depression, and a better overall quality of life. However, researchers are still trying to figure out how effective this care model really is for different patients.

To participate in this trial, individuals need to be at least 18 years old and have been admitted to the neurology department for at least one day. They should also be able to understand and communicate in Indonesian and have good cognitive function, meaning they can think clearly and make decisions. Participants will be asked to take part during their hospital stay and for eight weeks after they leave. This study is currently recruiting participants and is open to everyone, regardless of gender. It's important to note that those with serious speech problems or certain psychiatric disorders cannot join the trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being at least 18 years old, being admitted in neurology department for at least 24 to 48 hours,
  • Not having cognitive impairment as measured by the Montreal cognitive assessment (score ≥ 23),
  • Being able to communicate in Indonesia, having the ability to provide informed consent,
  • Being willing to participate in this study during hospitalization and 8 weeks after hospital discharge
  • Exclusion Criteria:
  • Have potentially biased information, such as being unable to provide informed consent due to cognitive impairment,
  • Having major speech and language problems or aphasia that prevent them from participating in the study,
  • Having serious psychiatric disorders or other with terminal disease requiring active treatment, and
  • Being discharged to a nursing home or welfare institution.

About Kaohsiung Medical University

Kaohsiung Medical University (KMU) is a leading educational and research institution located in Kaohsiung, Taiwan, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, KMU focuses on enhancing medical knowledge and improving patient outcomes across various fields, including medicine, nursing, and public health. The university's commitment to rigorous scientific inquiry and collaboration with healthcare professionals positions it at the forefront of clinical research, contributing significantly to the advancement of evidence-based practices and the development of new therapeutic interventions.

Locations

Kupang, , Indonesia

Patients applied

0 patients applied

Trial Officials

Bih-O Lee, Professor

Study Chair

Kaohsiung Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported